168 related articles for article (PubMed ID: 29317833)
1. Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis.
Liang C; Xu Y; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():47-57. PubMed ID: 29317833
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma.
Liang C; Xu Y; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():1203-1214. PubMed ID: 29551899
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis.
Liang C; Zhao J; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():3561-3571. PubMed ID: 29950861
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
5. Role of Beclin1 expression in patients with hepatocellular carcinoma: a meta-analysis.
Liang C; Li W; Ge H; Zhang K; Li G; Wu J
Onco Targets Ther; 2018; 11():2387-2397. PubMed ID: 29740214
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis.
Liang C; Xu Y; Ge H; Li G; Wu J
Onco Targets Ther; 2018; 11():1293-1303. PubMed ID: 29563808
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
Zhong C; Wu JD; Fang MM; Pu LY
Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta-analysis.
Chen Z; Zhang L; Zhu Q; Wang X; Wu J; Wang X
J Gastroenterol Hepatol; 2017 Mar; 32(3):567-576. PubMed ID: 28320060
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Liu GQ; Chen YG; Ma J; Lv GY
Int J Clin Exp Med; 2015; 8(4):4769-77. PubMed ID: 26131051
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.
Zhang Q; Zhou K; Liang W; Xiong W
J Int Med Res; 2020 Oct; 48(10):300060520962675. PubMed ID: 33100077
[TBL] [Abstract][Full Text] [Related]
13. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinical significance of VEGFR-3 in gastric cancer: A meta-analysis.
Ge H; Yan Y; Guo L; He X; Yang X
Clin Chim Acta; 2017 Nov; 474():114-119. PubMed ID: 28939099
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Prognostic Roles of the Expression Levels of the Programmed Cell Death-1 Gene in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Yang J; Zhang W; Zhang Z; Song F; Ding M; Zhao X; Wang W; Yang Y
Genet Test Mol Biomarkers; 2020 Oct; 24(10):641-648. PubMed ID: 32990474
[No Abstract] [Full Text] [Related]
19. Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis.
Zhou ZY; Liu SR; Xu LB; Liu C; Zhang R
J Clin Transl Hepatol; 2021 Dec; 9(6):889-897. PubMed ID: 34966652
[TBL] [Abstract][Full Text] [Related]
20. High expression of miR-21 is not a predictor of poor prognosis in all patients with hepatocellular carcinoma.
Yi PS; Li JS
Mol Clin Oncol; 2018 Jun; 8(6):733-739. PubMed ID: 29732156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
